We give you many useful information about health

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

We give you many useful information about health

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

We give you many useful information about health

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

We give you many useful information about health

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

We give you many useful information about health

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

Tampilkan postingan dengan label Smokers. Tampilkan semua postingan
Tampilkan postingan dengan label Smokers. Tampilkan semua postingan

Minggu, 04 Desember 2011

Wal-Mart's Health Plans for 2012 to Increase Premiums for Smokers

AppId is over the quota
AppId is over the quota

Penalty per pay period that Wal-Mart's health insurance plans will require of employees who smoke in 2012. The cost will amount to $260 to $2,340 extra per year for those who want health coverage. According to the benefits consulting firm Mercer, several other large employers also charge higher premiums to workers who smoke; among the largest employers, about 28% adjust their premiums based on workers' tobacco use. [via The New York Times]



News



Debt Financing

Rabu, 09 November 2011

Program urges smokers switch to smokeless tobacco

Translate Request has too much data
Parameter name: request
Translate Request has too much data
Parameter name: request
In this Thursday, Oct. 27, 2011 photo, a billboard by switchandquitowensboro.org stands along New Hartford Road in Owensboro, Ky. Dr. Brad Rodu, the director of the organization, and professor and researcher at the University of Louisville, is heading a new campaign for smokers to use smokeless tobacco in order to quit smoking, based on 20 years of research. (AP Photo/Stephen Lance Dennee) In this Thursday, Oct. 27, 2011 photo, a billboard by switchandquitowensboro.org stands along New Hartford Road in Owensboro, Ky. Dr. Brad Rodu, the director of the organization, and professor and researcher at the University of Louisville, is heading a new campaign for smokers to use smokeless tobacco in order to quit smoking, based on 20 years of research. (AP Photo/Stephen Lance Dennee) FILE - In this Sept. 28, 2010 file photo, smokeless tobacco products, including Ariva, are displayed in Richmond, Va. In the smoker-heavy state of Kentucky, a cancer center is suggesting something that most health experts won't and the tobacco industry can't: If you really want to quit, switch to smoke-free tobacco. (AP Photo/Steve Helber, File) Dr. Brad Rodu, the director of switchandquitowensboro.org, and a professor and researcher at the University of Louisville, displays his book "For Smokers Only," written in 1995 at his Louisville, Ky., office. Rodu is heading a new campaign for smokers to use smokeless tobacco in order to quit smoking, based on 20 years of research utilizing billboards, radio, print and other advertising. (AP Photo/Stephen Lance Dennee) In this Thursday, Oct. 27, 2011 photo, Dr. Donald Miller, director of the James Graham Brown Cancer Center, speaks during a news conference during a Breast Cancer Awareness Month postage stamp unveiling in Louisville, Ky. (AP Photo/Stephen Lance Dennee) In this Thursday, Oct. 27, 2011 photo, Dr. Brad Rodu, the director of switchandquitowensboro.org and a professor and researcher at the University of Louisville, looks through a microscope at a slide in his Louisville, Ky. Rodu is heading a new campaign for smokers to use smokeless tobacco in order to quit smoking, based on 20 years of research utilizing billboards, radio, print and other advertising. (AP Photo/Stephen Lance Dennee)eval("var currentItemd57851005a80479aaeeb90a12c70b9ff = 1;");eval("var nextd57851005a80479aaeeb90a12c70b9ff = 0;");eval("var previousd57851005a80479aaeeb90a12c70b9ff = 0;"); In the smoker-heavy state of Kentucky, a cancer center is suggesting something that most health experts won't and the tobacco industry can't: If you really want to quit, switch to smoke-free tobacco.

The James Graham Brown Cancer Center and the University of Louisville are aiming their "Switch and Quit" campaign at the city of Owensboro. It uses print, radio, billboard and other advertising to urge smokers to swap their cigarettes for smokeless tobacco and other products that do not deliver nicotine by smoke.

Supporters say smokers who switch are more likely to give up cigarettes than those who use other methods such as nicotine patches, and that smokeless tobacco carries less risk of disease than cigarettes do.

"We need something that works better than what we have," said Dr. Donald Miller, an oncologist and director of the James Graham Brown Cancer Center, which supports the effort along with the University of Louisville. "This is as reasonable a scientific hypothesis as anybody has come up with and it needs to be tried."

The campaign runs counter to the prevailing opinion of the public health community, which holds that there is no safe way to use tobacco. Federal researchers, however, have begun to at least consider the idea that smokers might be better off going smokeless.

The National Cancer Institute at the National Institutes of Health says on its website that the use of all tobacco products "should be strongly discouraged," and that there is "no scientific evidence that using smokeless tobacco can help a person quit smoking." But this year it approved funding for a study that might provide some of that very evidence.

"Switch and Quit" is directed by Brad Rodu, a professor of medicine at the University of Louisville. He analyzed the 2000 National Health Interview Survey and found that male smokers who switched to smokeless tobacco were more likely to quit smoking than those who used nicotine patches or gum.

"Americans are largely misinformed about the relative risks. ... They think smokeless tobacco is just as dangerous," Rodu said. "This level of misinformation is an enormous barrier to actually accomplishing tobacco-harm reduction because if people believe that the products have equal risk, there's not a real incentive."

The program is funded through Rodu's research money, which includes grants from the tobacco industry. Grants through the University of Louisville are unrestricted, which the program says "ensures the scientific independence and integrity of research projects and activities."

"There's absolutely no influence whatsoever," Rodu said. "I decide, along with my colleagues, how we use the money, for what projects, and this is entirely the case. I would not have a situation where there was some control over the kind of projects I undertake."

Tobacco companies want to market more smokeless tobacco and other cigarette alternatives to make up for falling cigarette sales. Some have introduced "snus" — small pouches like tea bags that users stick between the cheek and gum — and dissolvable tobacco — finely milled tobacco shaped into orbs, sticks and strips.

But they're barred by federal law from explicitly marketing them as less risky than cigarettes — at least for now. That means the "Switch and Quit" program can do something the tobacco industry itself cannot: claim that smokeless tobacco has a health benefit when compared to smoking.

The program says smoking kills about 220 adults a year in and around Owensboro. The state of Kentucky, a leading tobacco grower, has the nation's highest smoking and lung cancer rates.

Owensboro and the surrounding area consume about 3 million cigarettes a week, according to the program. That amounts to well over a pack for every man, woman and child in the community of about 115,000 people.

Owensboro resident Vernon Goode had smoked for about 10 years before he recently traded his Marlboros for dissolvable tobacco tablets. The campaign didn't inspire him to quit, but he said he thought it was a good idea.

"I was just wanting to quit because, you know, I could feel it in my lungs," Goode said. "I'll smoke a cigarette every once in a while, but not very often. I want to quit altogether and I'm just using this right here as I guess what you'd call a stepping stone."

The Owensboro program has raised concerns among some in the public health community who say organizers are claiming smokeless tobacco is a healthier alternative to smoking without approval from the Food and Drug Administration.

A 2009 law gives the FDA authority to evaluate health risks of tobacco products and approve those that could be marketed as safer than what's currently for sale. None have been given the OK yet. The FDA also plans to regulate electronic cigarettes, battery-powered plastic and metal devices that heat a liquid nicotine solution in a disposable cartridge, creating vapor that users inhale.

Matthew Myers, president of the Campaign for Tobacco-Free Kids, called the program "a giant experiment with the people of Owensboro without rules or guidance designed to protect individuals from experimental medicine."

Smokeless tobacco isn't a safe alternative to cigarettes, according to the Centers for Disease Control and Prevention. Health warnings on the products required by the FDA state the same thing.

However, some studies, including a 2007 report from the Royal College of Physicians in London titled "Harm Reduction in Nicotine Addiction," suggest that some smokeless tobacco products are about 90 percent less harmful than cigarettes.

"The worst that you can say about smokeless tobacco is that it's the lesser of two evils," said Dr. Randall Thomas, an oncologist with the Owensboro Medical Health System. The health system, the community's largest employer, is going smoke-free in 2013 and is offering Rodu's program as one of a variety of quit-smoking tools for its employees.

"I don't think we have any problem in telling a person that drinks a six-pack a day that if they could cut it back to two beers a day or two drinks a day that their health risks are greatly reduced," Thomas said. "Finding a way to let people have their nicotine that carries less risk, it's the realistic solution."

The Owensboro program doesn't suggest pharmaceutical nicotine replacement gum or patches. That's because they are regulated to provide very small doses of nicotine and are recommended for only a short period of time, while smokeless tobacco can be used as long as a smoker needs, Rodu said.

Myers, of the Campaign for Tobacco-Free Kids, said more research is needed before anyone should suggest that the nation's 46 million smokers would be better off using smokeless tobacco. In the meantime, he said, there are a host of FDA-approved products that can help people give up smoking.

"There's a right way and a wrong way to determine whether smokeless tobacco can and should be marketed as a way to help people quit," Myers said.

The National Cancer Institute approved funding earlier this year for a nationwide 1,250-person study to look at whether being given a snus product changes the habits of smokers who are not motivated to quit.

The tobacco industry sees smokeless tobacco as its future, said Matthew J. Carpenter, a psychology professor at the Medical University of South Carolina who is conducting the yearlong study.

Carpenter said the snus study will examine what smokers do when given smokeless tobacco. He won't look at the health effects, or advise smokers to use the snus to quit.

"They are probably safer than conventional cigarettes, if for no other reason than you're not burning anything, you're not smoking anything, you're not inhaling any smoke," he said.

"If you compare it to conventional cigarettes, they're probably a little bit better. If you compare it to quitting, they're absolutely worse."

___

Michael Felberbaum can be reached at http://www.twitter.com/MLFelberbaum.

Associated Press

Technology



News

Jumat, 14 Oktober 2011

Do hospitals do enough to help smokers quit?

AppId is over the quota
AppId is over the quota
A man smokes next to a ''No Smoking'' sign in downtown Shanghai April 27, 2011. REUTERS/Carlos Barria

A man smokes next to a ''No Smoking'' sign in downtown Shanghai April 27, 2011.

Credit: Reuters/Carlos Barria

By Kerry Grens

NEW YORK | Thu Oct 13, 2011 1:19pm EDT

NEW YORK (Reuters Health) - Nearly every smoker hospitalized in the United States is given advice or counseling on how to quit, according to a new study of hospital records.

But that finding belies what researchers consider a failed attempt, initiated nine years ago, at getting hospitals to actually help people stop smoking. The next version of the program needs to do better, experts say.

"There was no requirement, other than a box to check off that any substantive counseling was given to help smokers to quit," Dr. Michael Fiore, director of the Center for Tobacco Research and Intervention at the University of Wisconsin, told Reuters Health. He was not involved in the current study but chairs a panel working to revise the hospital rules on smokers.

In 2002, the Centers for Medicare and Medicaid Services and The Joint Commission, which sets hospital standards, required that smokers discharged after having pneumonia, heart attack or heart failure be given quitting advice.

It was almost too simple a request, said Douglas Levy, lead author of the new study and a professor at Harvard Medical School and the Mongan Institute for Health Policy at Massachusetts General Hospital.

"There are anecdotal reports of hospitals putting a postcard in the patient's room saying, 'you should quit smoking' and checking off the box that they've provided smoking cessation advice or counseling," Levy told Reuters Health.

Levy and his colleagues collected information from the Centers for Medicare and Medicaid Services on how often hospitals provided quitting advice to patients.

Their study, published in the Archives of Internal Medicine, shows how readily hospitals adopted the new measure.

In 2002, just 67 percent of smokers hospitalized because of a heart attack received advice on quitting smoking.

By 2008, that number jumped to 99 percent of heart attack patients.

For heart failure patients, 42 percent admitted to the hospital in 2002 received smoking cessation information, compared to 97 percent of patients in 2008.

Similarly for pneumonia patients, 37 percent of them were advised to quit smoking in 2002, compared to 95 percent in 2008.

The numbers show that hospitals paid attention to the rules, but the rules were too easy to satisfy, Levy said.

The Joint Commission recognized that the requirements were not strict enough, and they put together an advisory panel in 2009 to revise the rules. One of the study's authors sits on the panel.

Fiore, the panel's chairman, said one of the changes coming out in 2012 is that hospitals will have to follow up with people 30 days after they are discharged to check whether the patients were able to quit smoking.

In this way, hospitals can better gauge how well their efforts are paying off.

Levy's results don't show whether the higher rates of quitting advice resulted in more people quitting smoking.

Take-home advice from hospitals doesn't always change outcomes. Another recent study showed that hospitals that set up children and their families with a plan for managing asthma did not reduce later hospital visits for the condition (see Reuters Health story of October 4, 2011).

Fiore said he expects the new rules to be more effective at helping hospitals seize the opportunity to get smokers to quit.

Hospitals will also be required to document their efforts in more detail.

But Levy said some of his results left him concerned that certain hospitals may struggle under the stricter requirements.

The small numbers of patients who did not receive any advice on how to quit smoking were clustered at hospitals that serve a greater proportion of poor, minority or frail patients.

If these hospitals are not meeting the standards "when the bar is set low, it's going to be harder for them when the bar is set higher," Levy said.

He added that it will be important to make sure the most vulnerable hospitals don't fall behind.

SOURCE: bit.ly/rp6ipt, Archives of Internal Medicine, October 10, 2011.



New Automobile



Health Management

Sabtu, 01 Oktober 2011

Ranked: Jobs With the Most (and Fewest) Smokers

AppId is over the quota
AppId is over the quota

Miners, food service workers and construction workers are more likely to smoke than adults in other industries, the Centers for Disease Control and Prevention (CDC) reported on Thursday.

In an analysis of 2004-10 data from a national health survey, the CDC found that 30% of workers in mining and an equal proportion of workers in hotel and food services reported smoking. An estimated 29.7% of adults working in construction smoked.

The overall adult smoking rate in the U.S. is 19.3%.

"Targeted workplace tobacco control interventions have been effective in reducing smoking prevalence and exposure to secondhand smoke," the CDC said, noting that smoking rates among working adults fell from 27.8% in 1987-94 to 24.5% in 1997-2004.

But declines have plateaued in recent years, far above the Healthy People 2010 target rate of adult smoking of 12% or lower, so the agency sought to parse current smoking data by industry and occupation.

MORE: Guys, Quitting Smoking Makes It Bigger. Really.

Other industries with high smoking rates included waste management (24.3%), real estate (23.4%), manufacturing (23.2%) and retail (23.1%). Industries with the lowest rate of smoking included education services (9.7%), business management (10.9%), finance and insurance (13.9%), and science and tech services (14%).

The data further showed that smoking rates were higher in younger workers, the less educated and the poor. An estimated 23.8% of 18-to-24-year-old adults smoked, along with 28.4% of those who never graduated from high school, and 27.7% of adults living below the federal poverty line.

The CDC recommends increasing implementation of and employee access to measures that have been shown to lower workplace smoking and reduce secondhand-smoke exposure:

Smoke-free workplace policiesIndividual, group and phone-based quit-smoking counselingAntismoking drugsTailored print or Web-based smoking cessation materialsComprehensive insurance coverage for effective quit-smoking treatments

The CDC advises employers to ensure that all effective smoking-cessation treatments — counseling and drugs — is included as part of any basic health care plan that covers their employees. The 2010 health-care reform law requires new private health insurance plans to cover evidence-based quit-smoking treatments without cost-sharing, which should help more workers quit, the CDC said.

"Employers should educate all employees about the availability of these treatments and encourage their use," the CDC said. "Providing coverage for tobacco dependence treatment will increase access to services, which will improve the health of employees and result in lower rates of absenteeism and lower utilization of health care resources."

See the full CDC Morbidity and Mortality Weekly Report, and the full ranking of smoking rates by industry and specific job, here.

MORE: A Cheaper Way to Quit Smoking?



View the original article here



Peliculas Online

Jumat, 30 September 2011

Soviet-era pill from Bulgaria helps smokers quit

AppId is over the quota
AppId is over the quota
LONDON (AP) — A pill developed in Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big study of it shows.

It could become a new weapon to combat smoking in poor countries, but it is unclear whether it will ever reach the market in the U.S. or Western Europe.

The drug, cytisine, is now used just in Eastern Europe, where smokers usually take the pill for three or four weeks. Generic versions cost as little as $5 to $17 a month, compared with about $100 for an eight-week supply of nicotine patches or about $300 for a 12-week supply of Pfizer Inc.'s Chantix pill — common treatments in rich countries to help smokers quit.

Cytisine "is so cheap that even in developing countries, if you can afford to smoke, you can afford to stop," said Dr. Robert West of University College London. He led the study, published in Thursday's New England Journal of Medicine.

Cytisine, sold as Tabex by Sopharma AD, a Bulgaria-based company, is derived from laburnum seeds, which contain a natural nicotine substitute. West said it was discovered when much of the Soviet Union's drug research was farmed out to Bulgaria. Russian soldiers referred to it as "fake tobacco," West said.

New research suggests the drug can triple smokers' chances of being off cigarettes after one year compared with those taking a dummy pill.

It has been sold in Eastern Europe for about 40 years but has not been approved in Western Europe or the United States. Extab, a Sopharma subsidiary, has bought worldwide rights to sell it and plans to market it cheaply in developing countries like China and India.

Some experts are unsure it will ever make it to Western markets without larger trials — and without a big pharmaceutical stepping in to pay for them.

"It is possible that extensive bureaucracy and overcautious regulations will prevent its use in the U.S. and Europe," said Peter Hajek, director of the Tobacco Dependence Research Unit at Queen Mary University Hospital in London. Hajek said if a big drugmaker got involved, the price would probably jump.

About 95 percent of smokers who try to quit without help fail within six months, and more than two- thirds of the world's 1 billion smokers live in developing countries. Smoking is the world's leading cause of preventable death.

The new study was the first major test of cytisine's safety and effectiveness. It involved 740 smokers in Poland. For 25 days, half were given cytisine and half received dummy pills. Neither they nor their doctors knew which treatment they were getting. After one year, 2.4 percent of those on dummy pills had stopped smoking versus 8.4 percent of the people on cytisine (often pronounced like "citizen").

The study did not compare cytisine to other smoking-cessation treatments, but experts said the results were on par with those of many alternatives. It had a lower success rate than the 15 to 30 percent seen in studies with Chantix, but that drug carries warnings about possible psychiatric risks.

Nearly 14 percent of people taking cytisine reported stomach problems such as nausea, versus 8 percent of the people on dummy pills. There were two deaths in the group taking cytisine, from lung cancer and cardiac arrest, and three deaths in the placebo group, from lung cancer, stroke and respiratory problems. Dizziness and sleep problems were a little more common among cytisine users.

There have been no signs of any serious side effects in the more than 7 million people who have taken cytisine in the past 40 years, according to records from regulatory agencies in countries where the drug is licensed.

Patients are given the pills to satisfy their nicotine cravings, then are slowly weaned off the drug. They start with six pills a day, cutting down to just two by the end of the treatment.

The study was paid for by Britain's Medical Research Council, while the cytisine and the placebo pills were provided by Sopharma AD. West and one other study author reported having consulted for drugmakers, including several that make kick-the-habit products. West also has a patent pending on a nicotine delivery device.

Cytisine "looks promising, but the jury is still out," said Dr. Michael Fiore, director of the Center for Tobacco Research and Interventions at the University of Wisconsin, Madison, who had no role in the study. Fiore said that more studies are needed to confirm the findings, but that an inexpensive anti-smoking drug would be useful anywhere.

___

Online:

http://www.nejm.org/doi/full/10.1056/NEJMoa1102035

Associated Press

View the original article here



Peliculas Online

Rabu, 28 September 2011

Novartis seeks approval for new smoker's cough drug

AppId is over the quota
AppId is over the quota
By Aaron Gray-Block

AMSTERDAM | Tue Sep 27, 2011 1:30am EDT

AMSTERDAM (Reuters) - Swiss drugmaker Novartis said it has applied to start selling its experimental drug to treat smoker's cough -- which afflicts 80 million people worldwide -- after tests showed that it helped patients breathe more easily.

Novartis has carried out late-stage trials for the drug, known as NVA237, because it wants to tap into the lucrative market for respiratory drugs at a time when it is facing increasing competition for its top-selling products from generic rivals.

Analysts say Novartis could earn billions of dollars if its treatments for chronic obstructive pulmonary disease (COPD), commonly known as smoker's cough, win regulatory approval. NVA237 alone could potentially add $500 million in annual sales.

On Tuesday Novartis said NVA237, used once a day, significantly increased the functioning of lungs in patients compared with a placebo and that the first dose produced a fast response. NVA237 also enabled patients to exercise longer, it added.

Dave Morris, global development head at the Respiratory unit, said Novartis applied to the European Medicines Agency for approval at the end of August and expects a final decision from authorities some time in 2012. The drug will be marketed in the European Union as Seebri Breezhaler.

In a presentation at the European Respiratory Society annual meeting in Amsterdam, Novartis said NVA237 prolonged the time before patients suffered their first moderate to severe relapse and reduced the number of hospitalizations.

In June a separate study showed NVA237, or glycopyrronium bromide, helps patients with smoker's cough -- which causes breathing trouble and chronic coughing and is sometimes fatal, in a similar way to a rival drug from Pfizer and Boehringer Ingelheim.

Novartis wants to combine NVA237 with an inhalation powder indacaterol to treat the disease as it races British drugmaker GlaxoSmithKline to be the first company to sell a two-in-one medicine. The combined treatment is being developed under the name QVA149.

Data unveiled in Amsterdam also showed a 150 mcg and 300 mcg dose of Novartis' indacaterol drug significantly improved lung function among patients after using it for six months compared with patients who were treated with a placebo.

Earlier this year, U.S. authorities approved a 75 mcg dose, but Novartis failed to win backing for its higher 150 mcg dose, a setback for Novartis in its development of QVA149.

Deutsche Bank analyst Richard Parkes estimates that NVA237 could generate annual sales of $500m by 2018, while the combined treatment could add more than $2 billion to that figure.

NVA237 was licensed to Novartis in 2005 by Vectura and its co-development partner Sosei.

Until recently, Novartis was not on the radar as a major force in lung drugs, which are more difficult to make because of the inhaler devices needed.

The field is now becoming increasingly important to Novartis as it develops new drugs and cheap generic versions of older products such as Glaxo's Advair.

(Additional reporting by Katie Reid in Zurich)



View the original article here



Peliculas Online

Selasa, 20 September 2011

Smokers 'nudged' to go smokeless

AppId is over the quota
AppId is over the quota
15 September 2011 Last updated at 10:03 GMT By Victoria King Political reporter, BBC News Man smoking Tobacco smoke contains harmful toxins and carcinogens Encouraging smokers to switch to smokeless "fake" cigarettes could save tens of thousands of lives, according to a government-backed report.

The idea comes from the Cabinet Office Behavioural Insights Team - or "nudge unit" as it has been called.

It also says making people write "This is an honest account of the truth" on insurance claims forms could cut fraud.

But critics of the unit's activities have suggested there is little evidence that such "nudges" actually work.

The Behavioural Insights Team (BIT) was set up in July 2010, based around the ideas of two academics, Richard Thaler and Cass Sunstein, who believe that bad choices and laziness are a large part of what makes people human.

Therefore, they argue that instead of appealing to voters' self-interest, by for example urging people to eat more healthily, politicians must help to make the "right" choices "easier to make.

Drinking and debt

In its first annual report, the BIT said the government should promote the use of "safe" alternatives to cigarettes - products which deliver nicotine in a fine, pure vapour, instead of in harmful smoke which also contains toxins and carcinogens.

However, versions of smoke-free cigarettes are currently illegal in a number of countries, including Canada and Brazil, because their potential side-effects have not been fully investigated.

In the UK, medicines regulators have actively discouraged the development, marketing and promotion of cigarette substitutes containing nicotine because it is addictive, but they are now looking into approving such devices for use.

The BIT report also listed a number of other proposals in a range of policy areas - some of which are already being trialled - including:

making drinkers more aware of how much alcohol others consume - on the basis that most people overestimate how much others drink removing alcohol from prominent positions at the front of supermarkets - Asda, Morrisons and Waitrose have already done soredesigning hospital prescription charts to cut down on errors due to incorrect completion and bad handwritingproviding upfront rewards like shopping vouchers or council tax holidays to encourage household energy efficiency improvements - rafter than stressing the longer-term gains to be madealtering letters to tax debtors to inform them that the majority of people in their area have already paid up and reminding them of the link between tax and local services - trials showed a 15% improvement in response ratesplacing declarations of honesty at the start of forms, not the end, to "prime" respondents to tell the truth, or requiring them to write out, by hand, an "honesty sentence"

Some MPs and peers have criticised the cost of the BIT - which is more than £500,000 a year - and its potential effectiveness.

Its head, Cabinet Office minister Oliver Letwin, told the Lords science committee earlier this year that its ideas were not guaranteed to work, but said it was worth trying as the moves suggested were "pretty cost-free".

His comments came after a critical National Audit Office report in February which said the BIT had failed to convince a single government department to use its ideas.

The government said it agreed there were "few circumstances in which nudging alone is likely to be sufficient", but in addition to rules and regulations, "we have rightly been thinking about how we can encourage people to lead healthier lives through the application of behavioural insights and other non-regulatory instruments".

The annual report suggests that hundreds of millions of pounds could be saved if all its suggested measures are adopted.

In the case of unpaid tax, it estimates that sending amended letters to all self-assessment customers would free collectors up to chase an extra £30m in unpaid Exchequer revenue each year.



View the original article here



Peliculas Online

Minggu, 18 September 2011

Smokers 'nudged' to go smokeless

AppId is over the quota
AppId is over the quota
15 September 2011 Last updated at 10:03 GMT By Victoria King Political reporter, BBC News Man smoking Tobacco smoke contains harmful toxins and carcinogens Encouraging smokers to switch to smokeless "fake" cigarettes could save tens of thousands of lives, according to a government-backed report.

The idea comes from the Cabinet Office Behavioural Insights Team - or "nudge unit" as it has been called.

It also says making people write "This is an honest account of the truth" on insurance claims forms could cut fraud.

But critics of the unit's activities have suggested there is little evidence that such "nudges" actually work.

The Behavioural Insights Team (BIT) was set up in July 2010, based around the ideas of two academics, Richard Thaler and Cass Sunstein, who believe that bad choices and laziness are a large part of what makes people human.

Therefore, they argue that instead of appealing to voters' self-interest, by for example urging people to eat more healthily, politicians must help to make the "right" choices "easier to make.

Drinking and debt

In its first annual report, the BIT said the government should promote the use of "safe" alternatives to cigarettes - products which deliver nicotine in a fine, pure vapour, instead of in harmful smoke which also contains toxins and carcinogens.

However, versions of smoke-free cigarettes are currently illegal in a number of countries, including Canada and Brazil, because their potential side-effects have not been fully investigated.

In the UK, medicines regulators have actively discouraged the development, marketing and promotion of cigarette substitutes containing nicotine because it is addictive, but they are now looking into approving such devices for use.

The BIT report also listed a number of other proposals in a range of policy areas - some of which are already being trialled - including:

making drinkers more aware of how much alcohol others consume - on the basis that most people overestimate how much others drink removing alcohol from prominent positions at the front of supermarkets - Asda, Morrisons and Waitrose have already done soredesigning hospital prescription charts to cut down on errors due to incorrect completion and bad handwritingproviding upfront rewards like shopping vouchers or council tax holidays to encourage household energy efficiency improvements - rafter than stressing the longer-term gains to be madealtering letters to tax debtors to inform them that the majority of people in their area have already paid up and reminding them of the link between tax and local services - trials showed a 15% improvement in response ratesplacing declarations of honesty at the start of forms, not the end, to "prime" respondents to tell the truth, or requiring them to write out, by hand, an "honesty sentence"

Some MPs and peers have criticised the cost of the BIT - which is more than £500,000 a year - and its potential effectiveness.

Its head, Cabinet Office minister Oliver Letwin, told the Lords science committee earlier this year that its ideas were not guaranteed to work, but said it was worth trying as the moves suggested were "pretty cost-free".

His comments came after a critical National Audit Office report in February which said the BIT had failed to convince a single government department to use its ideas.

The government said it agreed there were "few circumstances in which nudging alone is likely to be sufficient", but in addition to rules and regulations, "we have rightly been thinking about how we can encourage people to lead healthier lives through the application of behavioural insights and other non-regulatory instruments".

The annual report suggests that hundreds of millions of pounds could be saved if all its suggested measures are adopted.

In the case of unpaid tax, it estimates that sending amended letters to all self-assessment customers would free collectors up to chase an extra £30m in unpaid Exchequer revenue each year.



View the original article here



Peliculas Online